Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124631573 | 12463157 | 3 | F | 20160302 | 20160811 | 20160614 | 20160816 | EXP | US-ROCHE-1771433 | ROCHE | 47.00 | YR | F | Y | 78.30000 | KG | 20160816 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124631573 | 12463157 | 1 | PS | Pertuzumab | PERTUZUMAB | 1 | Intravenous (not otherwise specified) | CYCLE 1 DAY 1 ?LOADING DOSE | 125409 | 840 | MG | SOLUTION FOR INFUSION | |||||||
| 124631573 | 12463157 | 2 | SS | Pertuzumab | PERTUZUMAB | 1 | Intravenous (not otherwise specified) | CYCLE 2-6 DAY 1?MOST RECENT DOSE ADMINISTERED: 26/FEB/2016 AND 08/APR/2016 (CYCLE 4, 420 MG)?MAINTE | 125409 | 420 | MG | SOLUTION FOR INFUSION | Q3W | ||||||
| 124631573 | 12463157 | 3 | SS | Trastuzumab | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | LOADING DOSE ON DAY 1 CYCLE 1 | 103792 | 8 | MG/KG | SOLUTION FOR INFUSION | |||||||
| 124631573 | 12463157 | 4 | SS | Trastuzumab | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | CYCLE 2-6 DAY 1?MAINTENANCE DOSE?MOST RECENT DOSE ADMINISTERED: 26/FEB/2016, 08/APR/2016 (CYCLE 4, 4 | 103792 | 6 | MG/KG | SOLUTION FOR INFUSION | Q3W | ||||||
| 124631573 | 12463157 | 5 | SS | DOCETAXEL. | DOCETAXEL | 1 | Intravenous (not otherwise specified) | CYCLE 1 DAY 1?CYCLE 2-6 DAY 1 RECEIVED ON 26 /FEB/2016 AND CYCLE 4 ON 08/APR/2016 (138MG) | 0 | 75 | MG/M**2 | Q3W | |||||||
| 124631573 | 12463157 | 6 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | AUC=6 MG/ML/MIN IV OVER 30-60 MIN ON DAY 1 Q3 WEEKS?CYCLE 2-6 DAY 1 RECEIVED ON 26 /FEB/2016 AND CYC | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124631573 | 12463157 | 1 | Breast cancer |
| 124631573 | 12463157 | 3 | Breast cancer |
| 124631573 | 12463157 | 5 | Breast cancer |
| 124631573 | 12463157 | 6 | Breast cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124631573 | 12463157 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124631573 | 12463157 | Enterocolitis infectious | |
| 124631573 | 12463157 | Hypokalaemia | |
| 124631573 | 12463157 | Nausea | |
| 124631573 | 12463157 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124631573 | 12463157 | 1 | 20160205 | 0 | ||
| 124631573 | 12463157 | 3 | 20160205 | 0 | ||
| 124631573 | 12463157 | 5 | 20160205 | 0 | ||
| 124631573 | 12463157 | 6 | 20160205 | 0 |